JMP Securities Starts Ocular Therapeutix (OCUL) at Market Outperform

JMP Securities initiated coverage on Ocular Therapeutix (NASDAQ: OCUL) with a Market Outperform rating and a price target of $21.00.

For an analyst ratings summary and ratings history on Ocular Therapeutix click here. For more ratings news on Ocular Therapeutix click here.

Shares of Ocular Therapeutix closed at $5.84 yesterday.

You May Also Be Interested In

• Northland Starts Granite Ridge Resources (GRNT) at Outperform, 'Deep Discount & Moving to FCF+'
• Stephens Starts Materion Corp. (MTRN) at Equal Weight
• Stephens Starts GXO Logistics Inc. (GXO) at Overweight